G-FINDER Report 2016: The biopharmaceutical industry confirms its status as a significant funder of neglected disease R&D
ifpma | February 16, 2017
IFPMA, the international association representing the innovative biopharmaceutical industry, welcomes the G-FINDER 2016[1] results, which shows that industry consolidated its status as a main funder of neglected disease R&D in 2015.